Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Giral

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Annals of Internal Medicine|July 5, 2018
Comparison of Five Major Guidelines for Statin Use in Primary PreventionPhilippe Giral
European Heart Journal|August 20, 2022
Targeted proteomics improves cardiovascular risk prediction in secondary prevention: the impact of statin treatment?Philippe Giral
The New England Journal of Medicine|August 14, 2020
Bempedoic Acid to Lower LDL Cholesterol - Safety and EfficacyPhilippe Giral
The New England Journal of Medicine|November 26, 2010
Retinopathy progression in type 2 diabetesPhilippe Giral, David Rosenbaum
Current Medical Research and Opinion|July 22, 2004
Risk stratification for the prevention of cardiovascular complications of hypertensionXavier Girerd, Philippe Giral
Servir (Lisbon, Portugal)|December 3, 2003
[How far should the level of LDL cholesterol be decreased?]Philippe Giral, Gerard Turpin
JAMA Cardiology|October 8, 2025
Inquiry Regarding Body Temperature Data in HuMAIN-HFpEF TrialWilfried Le Goff, Philippe Giral
Presse Medicale (Paris, France : 1983)|March 22, 2006
[Ezetimibe with statins]Christel Jublanc, Philippe Giral, Gérard Turpin
European Heart Journal|May 17, 2021
The neutrophil-lymphocyte ratio and incident atherosclerotic events: the impact of racial differences?Philippe Giral, Elisa Deflorenne, Anatol Kontush
Circulation|July 2, 2003
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorptionEric Bruckert, Philippe Giral, Philippe Tellier
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|July 5, 2018
Comparison of Five Major Guidelines for Statin Use in Primary PreventionPhilippe Giral
European Heart Journal|August 20, 2022
Targeted proteomics improves cardiovascular risk prediction in secondary prevention: the impact of statin treatment?Philippe Giral
The New England Journal of Medicine|August 14, 2020
Bempedoic Acid to Lower LDL Cholesterol - Safety and EfficacyPhilippe Giral
The New England Journal of Medicine|November 26, 2010
Retinopathy progression in type 2 diabetesPhilippe Giral, David Rosenbaum
Current Medical Research and Opinion|July 22, 2004
Risk stratification for the prevention of cardiovascular complications of hypertensionXavier Girerd, Philippe Giral
Servir (Lisbon, Portugal)|December 3, 2003
[How far should the level of LDL cholesterol be decreased?]Philippe Giral, Gerard Turpin
JAMA Cardiology|October 8, 2025
Inquiry Regarding Body Temperature Data in HuMAIN-HFpEF TrialWilfried Le Goff, Philippe Giral
Presse Medicale (Paris, France : 1983)|March 22, 2006
[Ezetimibe with statins]Christel Jublanc, Philippe Giral, Gérard Turpin
European Heart Journal|May 17, 2021
The neutrophil-lymphocyte ratio and incident atherosclerotic events: the impact of racial differences?Philippe Giral, Elisa Deflorenne, Anatol Kontush
Circulation|July 2, 2003
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorptionEric Bruckert, Philippe Giral, Philippe Tellier
Pageof 14